The future of pharmacologic stress: selective a2a adenosine receptor agonists

This publication has 8 references indexed in Scilit:

• Randomized, Controlled Dose-Ranging Study of the Selective Adenosine A _2A Receptor Agonist Binodenoson for Pharmacological Stress as an Adjunct to Myocardial Perfusion Imaging
  Circulation, 2004
• A_2BAdenosine Receptors Increase Cytokine Release by Bronchial Smooth Muscle Cells
  American Journal of Respiratory Cell and Molecular Biology, 2004
• Comparative Profile of Vasodilation by CVT-3146, a Novel A2A Receptor Agonist, and Adenosine in Conscious Dogs
  The Journal of Pharmacology and Experimental Therapeutics, 2003
• Selective A2A Adenosine Receptor Agonist as a Coronary Vasodilator in Conscious Dogs: Potential for Use in Myocardial Perfusion Imaging
  Journal of Cardiovascular Pharmacology, 2003
• Induction of interleukin 8 release from the HMC-1 mast cell line: Synergy between stem cell factor and activators of the adenosine A2b receptor
  Biochemical Pharmacology, 2002
• A _2A -Adenosine Receptor Reserve for Coronary Vasodilation
  Circulation, 1998
• Adenosine A2B receptors: a novel therapeutic target in asthma?
  Trends in Pharmacological Sciences, 1998
• Adenosine A2b receptors evoke interleukin-8 secretion in human mast cells. An enprofylline-sensitive mechanism with implications for asthma.
  Journal of Clinical Investigation, 1995